EDSA Stock Analysis: Buy, Sell, or Hold?
EDSA - Edesa Biotech, Inc. Common Shares
$14.26
3.09 (27.66%)
▲
5d:
+86.41%
30d:
+145.02%
90d:
+933.33%
WAIT
LOW Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 13, 2026
13d
Get Alerted When EDSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: EDSA is 66.0% above its trading range ($8.59). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: EDSA is 66.0% above its trading range ($8.59). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: EDSA is currently trading at $14.26, which is considered extended relative to its 30-day fair value range of $4.77 to $8.59.
Technical Outlook: Technically, EDSA is in a strong uptrend. Immediate support is located at $5.06, while resistance sits at $15.50. The stock is showing strong short-term momentum, up 27.7% recently.
Market Sentiment: EDSA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $11.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EDSA is in a strong uptrend. Immediate support is located at $5.06, while resistance sits at $15.50. The stock is showing strong short-term momentum, up 27.7% recently.
Market Sentiment: EDSA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $11.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.77 -
$8.59
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+66.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+27.7%)
- BEARISH: Trading 22.9% above Wall St target ($11.00)
- WARNING: Recommendation downgraded due to 66.0% overvaluation
Trading Range Analysis
30-Day Trading Range
$4.77 -
$8.59
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$5.06
Resistance Level
$15.50
Current Trend
Strong Uptrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.20
Wall Street Target
$11.00
(-22.9%)
Revenue Growth (YoY)
-99.9%
Share & Embed Analysis
Last updated: April 29, 2026 6:07 AM ET
Data refreshes hourly during market hours. Next update: 7:07 AM
Data refreshes hourly during market hours. Next update: 7:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EDSA showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Pardeep Nijhawan
BUY
1000 shares
2026-03-10
Pardeep Nijhawan
BUY
10000 shares
2026-03-05
Pardeep Nijhawan
BUY
10000 shares
2026-03-03
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$224 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 53 HOLD |
